Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Tweet this
Print
Valerio Dacrema, Pharm.D.
Pharmacology Unit, Humanitas Clinical and Research Center, IRCCS, Rozzano, 20089, Italy, Italy
Poster(s):
(P 117) SHOULD REGORAFENIB BE PRESCRIBED AS A CONTINUOUS SCHEDULE AT LEAST IN GASTROINTESTINAL STROMAL TUMORS (GIST)?
